Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Everest Group (EG)
NYSEFinancialsInsurance - ReinsuranceSnapshot 2026-11-04
$417.79-0.83%
Close 2026-11-05 · 1-day change
NYSEFinancialsInsurance - ReinsuranceSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
60.09 → 60.74 EPS · FY ending Dec 31, 2027 · 10 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 10 to 10; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for EG yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Share repurchases of at least $331 million in Q1 2026 | Everest Group buys back $331 million in shares, showing strong capital return. | Intact | share repurchases fall below $331 million in Q1 2026 | Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
EG is a value-oriented financials business with capital-return and specialty-growth elements, rather than a clear, steady compounder at present. Its long-term thesis is in a watch state: recent performance is weak, while management’s progress on underwriting is mixed.
The valuation is tagged as stretched, even though EG is cheap versus peers, so the expectations gap is modest rather than a clear cushion. The supplied evidence shows low fragility, but does not indicate that the weak recent results are fully reflected in expectations.
Near term, the latest earnings miss and consecutive run of misses weigh on the picture; the signal shifted to mixed and company momentum fell after the report. Through 2026-Q3, repurchases remained substantial, but the core combined ratio worsened to 105.8% and reserve strengthening complicated the underwriting record. Global Wholesale & Specialty premiums grew on a comparable basis, with a 97.3% combined ratio, but the evidence does not yet show broad improvement across core businesses.
The near-term test is whether guidance is cut on the next call, which the evidence flags as a meaningful negative. The multi-year view also depends on underwriting improvement and continued specialty growth; falling interest rates could weigh on the financials backdrop, while strong results and higher guidance from sector peers could support momentum.
Over the next 1 to 3 years, EG’s long-term thesis depends on whether capital returns and specialty growth can be matched by better, more consistent underwriting. The peer valuation discount is a point of support, but weak recent performance keeps execution in focus. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Everest Group's published investment case. The stated target is >=16.08 USD per share. |
| Intact |
| EPS falls below $16.08 per share in 2026 |
Diluted EPS: $6.12 per share FY2026-Q3; GAAP. Published target: >=16.08 USD per share. Target period ends 2026-12-31; this observation covers 2026-Q3. Oct 30, 20266.12 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Gross written premiums growth of at least 1.6% in Global Wholesale & Specialty | It grew premiums 1.6% in Global Wholesale & Specialty markets. | Intact | premium growth falls below 1.6% YoY in 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$60.15 → $60.74 · observed estimates
$15.30B → $14.09B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $60.15 | $15,300,913,655 | 9 / 4 |
| 2026-07-25 | $60.45 | $13,178,800,000 | 15 / 5 |
| 2026-07-26 | $60.15 | $15,300,913,655 | 9 / 4 |
| 2026-07-27 | $60.15 | $15,300,913,655 | 9 / 4 |
| 2026-07-28 | $60.15 | $15,300,913,655 | 9 / 4 |
| 2026-07-29 | $60.45 | $13,178,800,000 | 15 / 5 |
| 2026-07-30 | $59.95 | $15,300,913,650 | 9 / 4 |
| 2026-07-31 | $60.08 | $13,178,800,000 | 15 / 5 |
| 2026-08-01 | $59.95 | $15,156,368,828 | 9 / 4 |
| 2026-08-02 | $60.08 | $12,739,066,670 | 14 / 6 |
| 2026-08-03 | $60.02 | $15,099,823,075 | 9 / 4 |
| 2026-08-04 | $60.08 | $12,739,066,670 | 14 / 6 |
| 2026-08-05 | $60.02 | $15,099,823,075 | 9 / 4 |
| 2026-08-06 | $60.08 | $12,739,066,670 | 14 / 6 |
| 2026-08-07 | $60.02 | $15,099,823,075 | 9 / 4 |
| 2026-08-08 | $60.17 | $12,524,733,330 | 14 / 6 |
| 2026-08-09 | $60.17 | $12,524,733,330 | 14 / 6 |
| 2026-08-10 | $60.02 | $15,099,823,075 | 9 / 4 |
| 2026-08-11 | $60.02 | $15,099,823,075 | 9 / 4 |
| 2026-08-12 | $59.95 | $12,374,485,710 | 14 / 7 |
| 2026-08-13 | $60.02 | $15,099,823,075 | 9 / 4 |
| 2026-08-14 | $60.02 | $15,099,823,075 | 9 / 4 |
| 2026-08-15 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-16 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-17 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-18 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-19 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-20 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-21 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-22 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-23 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-24 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-25 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-26 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-27 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-28 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-29 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-30 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-31 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-01 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-02 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-03 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-04 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-05 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-06 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-07 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-08 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-09 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-10 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-11 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-12 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-13 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-14 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-15 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-16 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-17 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-18 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-19 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-20 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-21 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-22 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-23 | $60.02 | $14,418,586,031 | 9 / 6 |
| 2026-09-24 | $60.02 | $14,418,586,031 | 9 / 6 |
| 2026-09-25 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-26 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-27 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-28 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-29 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-30 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-10-01 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-10-02 | $60.10 | $14,418,586,031 | 10 / 6 |
| 2026-10-03 | $60.09 | $14,418,586,031 | 10 / 6 |
| 2026-10-04 | $60.09 | $14,418,586,031 | 10 / 6 |
| 2026-10-05 | $60.09 | $14,418,586,031 | 10 / 6 |
| 2026-10-06 | $60.08 | $14,424,654,159 | 10 / 6 |
| 2026-10-07 | $59.97 | $14,398,223,836 | 10 / 6 |
| 2026-10-08 | $59.91 | $14,227,123,836 | 10 / 6 |
| 2026-10-09 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-10 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-11 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-12 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-13 | $60.11 | $14,237,549,836 | 10 / 6 |
| 2026-10-14 | $60.11 | $14,237,549,836 | 9 / 6 |
| 2026-10-15 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-16 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-17 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-18 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-19 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-20 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-21 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-22 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-23 | $60.11 | $14,237,549,836 | 9 / 5 |
| 2026-10-24 | $60.11 | $14,237,178,657 | 10 / 6 |
| 2026-10-25 | $60.11 | $14,237,178,657 | 10 / 6 |
| 2026-10-26 | $60.11 | $14,237,178,657 | 10 / 6 |
| 2026-10-27 | $60.11 | $14,237,178,657 | 10 / 6 |
| 2026-10-28 | $60.11 | $14,237,178,657 | 10 / 6 |
| 2026-10-29 | $60.37 | $14,237,176,103 | 10 / 6 |
| 2026-10-30 | $60.58 | $14,221,776,103 | 10 / 6 |
| 2026-10-31 | $60.40 | $14,191,831,559 | 10 / 5 |
| 2026-11-01 | $60.40 | $14,191,831,559 | 10 / 5 |
| 2026-11-02 | $60.40 | $14,191,831,559 | 10 / 5 |
| 2026-11-03 | $60.48 | $14,093,833,503 | 10 / 4 |
| 2026-11-04 | $60.74 | $14,093,831,063 | 10 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 10 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 9 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.